STATEN ISLAND, N.Y. — The U.S. Food and Drug Administration (FDA) has announced a recall of 89,312 bottles of a popular nasal spray that may cause “adverse” effects. The NasoGel was recalled by the ...

Retired electrician Joe Walsh in December became the first Alzheimer’s patient to try a nasal spray used to treat other ...

Keymed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental ...

The Food and Drug Administration recently expanded approval for Spravato, an antidepressant nasal spray used to treat ...

Now, the new FDA approval means that patients will be able use the ketamine-derived nasal spray, which is marketed under the brand name Spravato, without having to be on another type of antidepressant ...

Nasal administration of ETH47 continued to demonstrate localized dose-dependent interferon lambda protein expression and target engagement ETH47 was generally safe and well-tolerated at all dose ...

Before we get to our kratom dosage chart, let’s briefly examine one of the most exclusive kratom strains, Dragon kratom. This kratom strain is naturally growing only on the lush green island of ...

MDR Certification Strengthens Resyca's Leadership in Soft Mist Drug-Device Combination Products ... user-friendly soft mist inhalation and soft nasal spray devices, incorporating the proprietary ...

By clicking on this link, we may receive a commission. Learn more. Nasal decongestant spray can help relieve sinus infection symptoms in the short term. But you should limit your use to no more ...

The U.S. Food and Drug Administration (FDA) approved the antidepressant nasal spray Spravato as a standalone treatment for depression in adults.

(HealthDay News) — The US Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at ...